Compliance
An In-Depth Review of AAHP’s 2021 Summit
By Eric L. Foxman, Pharmacist, AAHP Secretary Having listened to the speakers at AAHP’s 2021 Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2, I came away with several thoughts that will be important to manufacturers and marketers in the coming months and years. But first a huge thank you readm more…
Read MoreSuccess: Implementing HPUS Guidelines for FDA Compliance, Part 2
By Mark Land, AAHP President Co-hosted by AAHP and HPCUS on June 15, the Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2 was an overwhelming success from multiple perspectives. This was the second installment of a compliance program being developed by the Homeopathic Pharmacopoeia Convention of the United States readm more…
Read MoreHomeopathy’s Path Ahead: 5 Ways We’re Moving the Needle Together
A glance at AAHP and HPCUS’ multi-year, industry-wide initiative to clarify ambiguities in homeopathic manufacturing. Homeopathy’s path forward is a collective effort between manufacturers, scientists, homeopathic practitioners, and regulators. Stemming from AAHP’s first Summit in 2019 with FDA keynote speaker Francis Godwin, the industry identified five key areas where readm more…
Read MoreThe Importance of AAHP’s 2021 Summit
Implementing HPUS Guidelines for FDA Compliance, Part 2 By Mark Land, AAHP President AAHP’s newsletter editor asked me to write an article explaining the importance of the upcoming June 15 Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2. This Summit is the second installment of a compliance readm more…
Read MoreHomeopathic Pharmacopoeia Convention Activities 2020–2021
In early May, Eric Foxman, AAHP Secretary and Senior Scientist with HCPUS, presented a webinar on updates and activities of the Homeopathic Pharmacopoeia Convention of the United States. He noted that over the past 12 months, the HPCUS held almost 40 meetings; the pandemic circumstances forced all to be held readm more…
Read MoreFDA Eyes Improvements to Nonprescription Drug Labeling
What impact will that have on your products? The top line: Two years after issuing draft guidance on “innovative” nonprescription drug labeling, FDA is again thinking about potential improvements to the Drug Facts Label. First, let’s explain a bit about the regulation of labels for nonprescription drugs. Nonprescription, or over-the-counter readm more…
Read MoreAAHP Disclaimer: Continuing to Deliver Value After Five Years
The AAHP disclaimer, “Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated,” benefits from the best support among disclaimers I have seen – Use It! Mark Land, AAHP President In preparing to write this article, I reviewed a report I wrote about a year before readm more…
Read MoreAAHP Disclaimer Helps Win Two Lawsuits
Advancing Goal of Informing Consumers & Protecting Sellers By Alvin J. Lorman, Association Counsel If you’ve wondered whether the American Association of Homeopathic Pharmacists’ (AAHP) recommended consumer label and advertising disclaimer deserves the valuable space it occupies, we now have a judicial answer. AAHP’s disclaimer: “Claims based on readm more…
Read MoreYour Reputation Precedes You
By Mark Land, AAHP President | Brian Westerlind, Editor of the Network News, writes in his article on warning letters – “Each day AAHP works to promote excellence in the practice of homeopathic manufacturing. While achieving true excellence is a lofty goal, it begins with a few simple principles you can start to implement today.”
Read More4 Simple Ways to Keep Your Homeopathic Manufacturing Process Safe and Effective
Each day AAHP works to promote excellence in the practice of homeopathic manufacturing. While achieving true excellence is a lofty goal, it begins with a few simple principles you can start to implement today.
We’ve reviewed recent Warning Letters from the U.S. FDA—which highlight some of the most common missteps and shortcomings—and have put together these four basic ground rules that can help any homeopathic manufacturer or marketer strive toward excellence.
Read More